ARTICLE | Company News

Management tracks: Anchiano, ContraFect

November 13, 2018 11:26 PM UTC

Cancer company Anchiano Therapeutics Inc. (Tel Aviv:ANCN) appointed Stephen Hoffman chairman. He is CEO of Aerpio Pharmaceuticals Inc. (OTCQB:ARPO). Anchiano also named Robert Connelly a director. He was a venture partner at Flagship Pioneering and CEO of Axcella Health Inc. (Cambridge, Mass.).

Infectious disease company ContraFect Corp. (NASDAQ:CFRX) promoted SVP of Finance Michael Messinger to CFO...